CHU de Liège
Liège, Belgium
Location status: Recruiting
NCT Number: NCT06502873
The objective of this study is to constitute cohorts of IBD versus non-IBD patients to identify (a) new biomarker(s) of intestinal dysbiosis associated with inflammatory bowel disease, and develop a prototype for assaying such marker(s) in blood.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Liège, Belgium
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
General criteria:
Specific for Crohn cohort:
A clinical activity defined by a modified Mayo score ≥ 3 OR a Simple Clinical Colitis Activity Index ≥5 OR Patient Reported Outcome (PRO2) ≥ 4 with a subscore of rectal bleeding ≥1 OR a faecal calprotectin ≥ 250 µg/g AND An endoscopic activity defined by a Mayo endoscopic sub-score ≥ 2
Specific for Control cohort:
Patient with no colonic lesion(s) visible during the endoscopical examination (neither Crohn's nor other colitis nor cancer)
Exclusion criteria
General criteria:
Specific for Crohn cohort:
Collection of biological samples from the same cohorts: faeces, serum, intestinal biopsies
Time frame: 27 months
60 patients in IBD cohort and 60 patients in control cohort
Time frame: 27 months
60 patients in IBD cohort and 60 patients in control cohort
Time frame: 27 months
60 patients in IBD cohort and 60 patients in control cohort
Time frame: 27 months
60 patients in IBD cohort and 60 patients in control cohort with 4 colonic biopsies/ patient
Contact information is provided by the study sponsor or research team.
Artialis
Industry
Setting up a Cohort of Patients With Inflammatory Bowel Disease and a Cohort of Patients Without Chronic Inflammatory Bowel Disease in the Context of the Translational Study of Biomarkers of Intestinal Dysbiosis (ELITE Walloon Project)
Acronym: ELITE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07716488
Cardiovascular Abnormalities, Cardiovascular Diseases
Jena, Germany
View Trial DetailsNCT07224113
Colitis, Colitis, Ulcerative
Hartford, Connecticut, United States
View Trial DetailsNCT07368972
Anemia, Digestive System Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT07245394
Colitis, Colitis, Ulcerative
Calgary, Alberta, Canada
View Trial Details